Amy Marie Yule, MD

Associate Professor, Psychiatry

Amy Yule
720 Harrison Ave

Other Positions

  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University


  • University of California, Los Angeles, MD
  • University of California, San Diego, BS


  • Published on 3/19/2024

    Schoenberger SF, Cummins ER, Carroll JJ, Yan S, Lambert A, Bagley SM, Xuan Z, Green TC, Cook F, Yule AM, Walley AY, Formica SW. "Wanna cry this out real quick?": an examination of secondary traumatic stress risk and resilience among post-overdose outreach staff in Massachusetts. Harm Reduct J. 2024 Mar 19; 21(1):66. PMID: 38504244.

    Read at: PubMed
  • Published on 3/2/2024

    Kramer J, Perez D, Ramseier D, Morgan L, Wilens TE, Rao V, Yule AM. Patient Experiences Completing Patient Reported Outcome Measures in Behavioral Health Within a Health Safety-Net Setting. Community Ment Health J. 2024 Mar 02. PMID: 38430286.

    Read at: PubMed
  • Published on 3/1/2024

    Marshall A, Fai C, Han J, Yule AM, Jangi S. Rising Inpatient Utilization and Costs of Cannabis Hyperemesis Syndrome Hospitalizations in Massachusetts After Cannabis Legalization. J Clin Gastroenterol. 2024 Mar 01; 58(3):247-252. PMID: 37224284.

    Read at: PubMed
  • Published on 1/17/2024

    Yule AM, Youn SJ, Dean K, Woodward DW, Firmin ES, Kramer J, Stone M, Marques L, Wilens TE. Different factors identified by stakeholder group for barriers and facilitators to measurement-based care implementation in behavioral health clinics. J Clin Psychol. 2024 Mar; 80(3):576-590. PMID: 38230918.

    Read at: PubMed
  • Published on 1/3/2024

    Yule AM, Mail V, Butler R, Wilens TE. Medication Treatment for Youth in Substance Use Disorder Residential Treatment. J Atten Disord. 2024 Mar; 28(5):791-799. PMID: 38166518.

    Read at: PubMed
  • Published on 10/4/2023

    Park TW, Baul TD, Morgan JR, Wilens TE, Yule AM. Trends in Attention-Deficit Hyperactivity Disorder Diagnosis and Pharmacotherapy Among Adults With Opioid Use Disorder. Psychiatr Serv. 2024 Mar 01; 75(3):214-220. PMID: 37789727.

    Read at: PubMed
  • Published on 8/1/2023

    Perry R, Elek E, D'Amico E, Dickerson D, Komro K, Walton M, Razuri EB, Yule AM, Skinner J, Pendergrass T, Larkin K, Johnson C, Bonar EE, Oudekerk BA, Hairgrove S, Liu S, Graham P. Including Community Partners in the Development and Adaptation of Intervention Strategies to Prevent Initiation or Escalation of Opioid Misuse. Prev Sci. 2023 Oct; 24(Suppl 1):61-76. PMID: 37526787.

    Read at: PubMed
  • Published on 6/22/2023

    Rao V, Lanni S, Yule AM, DiSalvo M, Stone M, Berger AF, Wilens TE. Diagnosing major depressive disorder and substance use disorder using the electronic health record: A preliminary validation study. J Mood Anxiety Disord. 2023 Aug; 2. PMID: 37693103.

    Read at: PubMed
  • Published on 6/2/2023

    Yule AM, Fernandes CF, Stormshak EA, Yang Y, Shelley L, Fiellin LE, Larkin K, Ridenour TA, Saavedra LM, Kelleher K, Feng X, Walton MA, Bonar EE. Multidisciplinary Strategies for Preventing Opioid Misuse and Escalation by Targeting Mental Health Symptoms and Conditions. Prev Sci. 2023 Oct; 24(Suppl 1):77-87. PMID: 37266870.

    Read at: PubMed
  • Published on 4/1/2023

    McKowen J, Berger A, Towbin J, Yule AM, Woodward D, Nowinski L, Forchelli G, Meyers RJ, Joshi G, Wilens TE. A Manualized Behavioral Therapy Intervention for Youth with Autism Spectrum Disorder and Substance Use Disorder. Case Rep Psychiatry. 2023; 2023:8998160. PMID: 37038552.

    Read at: PubMed

View 55 more publications: View full profile at BUMC

View all profiles